{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:02:20Z","timestamp":1784120540924,"version":"3.55.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.ackd.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T19:33:18Z","timestamp":1657308798000},"page":"127-140.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hematological Malignancies and the Kidney"],"prefix":"10.1053","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-2287","authenticated-orcid":false,"given":"Matthew","family":"Abramson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1053\/j.ackd.2022.02.003_bib1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, Regional, and National cancer incidence, mortality, Years of Life Lost, Years lived with Disability, and Disability-Adjusted Life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of disease study","volume":"4","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1053\/j.ackd.2022.02.003_bib3","doi-asserted-by":"crossref","first-page":"272961","DOI":"10.1155\/2014\/272961","article-title":"Acute kidney injury in lymphoma: a single centre experience","volume":"2014","author":"Khalil","year":"2014","journal-title":"Int J Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib4","first-page":"416","article-title":"Renal complications in acute leukemias","volume":"83","author":"Munker","year":"1998","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib5","doi-asserted-by":"crossref","first-page":"e55870","DOI":"10.1371\/journal.pone.0055870","article-title":"Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival","volume":"8","author":"Canet","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2013.07.004","article-title":"Kidney involvement in leukemia and lymphoma","volume":"21","author":"Luciano","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0609.2005.00547.x","article-title":"Alterations in electrolyte equilibrium in patients with acute leukemia","volume":"75","author":"Filippatos","year":"2005","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib8","first-page":"84","article-title":"Lysozyme-induced nephropathy","volume":"2","author":"Santoriello","year":"2017","journal-title":"Kidney Int Rep Elsevier Inc"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000351804","article-title":"Spurious electrolyte disorders: a diagnostic challenge for clinicians","volume":"38","author":"Liamis","year":"2013","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/1947-2714.110426","article-title":"Errors in potassium measurement: a laboratory perspective for the clinician","volume":"5","author":"Asirvatham","year":"2013","journal-title":"North Am J Med Sci"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00277-012-1547-6","article-title":"Renal failure secondary to leukemic infiltration of kidneys in CLL--a case report and review of literature","volume":"92","author":"Uprety","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1053\/j.ackd.2022.02.003_bib12","unstructured":"Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood\u00a082."},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/10428190310001593139","article-title":"Diffuse large B-cell lymphoma presenting with hypercalcemia and multiple osteolysis. Leukemia and Lymphoma","volume":"45","author":"Matsuhashi","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/20009666.2020.1761185","article-title":"Diagnosis and management of tumor lysis syndrome","volume":"10","author":"Puri","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib15","first-page":"1322","article-title":"Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: Evidence for elevated levels in plasma from patients with adult T-cell leukemia\/lymphoma and B-cell lymphoma","volume":"79","author":"Ikeda","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00277-019-03890-w","article-title":"Hypercalcemia is associated with a poor prognosis in lymphoma a retrospective monocentric matched-control study and extensive review of published reported cases","volume":"99","author":"Vallet","year":"2020","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib17","first-page":"47","article-title":"Onconephrology: the intersections between the kidney and cancer","volume":"71","author":"Rosner","year":"2021","journal-title":"CA: A Cancer J Clinicians"},{"issue":"7","key":"10.1053\/j.ackd.2022.02.003_bib18","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.jcjd.2019.07.088","article-title":"79 - tumor Genesis syndrome: severe Hypophosphatemia associated with progression of diffuse large B-cell lymphoma","volume":"43","author":"Radi","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1053\/j.ackd.2022.02.003_bib19","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1100\/tsw.2011.125","article-title":"Type B lactic acidosis secondary to malignancy: case report, review of published cases, insights into pathogenesis, and prospects for therapy","volume":"11","author":"Ruiz","year":"2011","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2017.1270754","article-title":"Hyperleukocytosis and leukostasis: management of a medical emergency","volume":"10","author":"Giammarco","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"8","key":"10.1053\/j.ackd.2022.02.003_bib21","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrneph.2015.81","article-title":"Kidney diseases associated with haematological cancers","volume":"11","author":"Ganguli","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib22","first-page":"Ecr21","article-title":"Acute renal cortex necrosis caused by arterial thrombosis during treatment for acute promyelocytic leukemia","volume":"88","author":"Levin","year":"2003","journal-title":"Haematologica"},{"issue":"9","key":"10.1053\/j.ackd.2022.02.003_bib23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s002770000162","article-title":"Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis","volume":"79","author":"Thi\u00e9baut","year":"2000","journal-title":"Ann Hematol"},{"issue":"Suppl 1","key":"10.1053\/j.ackd.2022.02.003_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000168196","article-title":"Coagulation factors in nephrotic syndrome","volume":"10","author":"Kanfer","year":"1990","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.ackd.2022.02.003_bib25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fonc.2020.00815","article-title":"Hyperviscosity syndrome in paraprotein Secreting conditions including Waldenstrom macroglobulinemia","volume":"10","author":"Weaver","year":"2020","journal-title":"Front Oncol"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib26","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","article-title":"Evidence-based focused review of management of hyperviscosity syndrome","volume":"119","author":"Stone","year":"2012","journal-title":"Blood"},{"issue":"9813","key":"10.1053\/j.ackd.2022.02.003_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinemia","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/asheducation-2005.1.368","article-title":"Cryoglobulinemia","volume":"2005","author":"Morra","year":"2005","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"19","key":"10.1053\/j.ackd.2022.02.003_bib29","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with non\u2013hepatitis C virus\u2013related mixed cryoglobulinemia","volume":"166","author":"Saadoun","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2016-09-719773","article-title":"How I treat cryoglobulinemia","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.kint.2016.09.045","article-title":"Thrombotic microangiopathy associated with monoclonal gammopathy","volume":"91","author":"Ravindran","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-2369-13-172","article-title":"Membranoproliferative glomerulonephritis complicating Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"13","author":"Kratochvil","year":"2012","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.14279","article-title":"Renal disease related to Waldenstr\u00f6m macroglobulinaemia: incidence, pathology and clinical outcomes","volume":"175","author":"Vos","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2215\/CJN.01600408","article-title":"Renal lesions associated with IgM-Secreting monoclonal Proliferations: Revisiting the disease spectrum","volume":"3","author":"Audard","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2022.02.003_bib36","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3324\/haematol.2015.128793","article-title":"Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience","volume":"100","author":"Strati","year":"2015","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2015.02.340","article-title":"Thrombotic microangiopathy, cancer, and cancer drugs","volume":"66","author":"Izzedine","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2022.02.003_bib38","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","article-title":"Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature","volume":"45","author":"Usui","year":"2014","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Boll\u00e9e","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib40","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ndt\/gfp666","article-title":"Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy","volume":"25","author":"Costero","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib41","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1016\/j.transproceed.2018.07.020","article-title":"Development of focal segmental glomerulosclerosis and thrombotic microangiopathy in a liver transplant patient on sorafenib for Hepatocellular carcinoma: a case report","volume":"50","author":"Hanna","year":"2018","journal-title":"Transpl Proc"},{"key":"10.1053\/j.ackd.2022.02.003_bib42","first-page":"4327904","article-title":"Thrombotic thrombocytopenic purpura associated with pazopanib","volume":"2018","author":"Syed","year":"2018","journal-title":"Case Rep Hematol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15586\/jkcvhl.v8i1.161","article-title":"Thrombotic microangiopathy associated with pazopanib in a kidney transplant Recipient","volume":"8","author":"Kalla","year":"2021","journal-title":"J Kidney Cancer VHL"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1159\/000494080","article-title":"Thrombotic microangiopathy with severe proteinuria induced by lenvatinib for Radioactive Iodine-refractory Papillary Thyroid carcinoma","volume":"11","author":"Hyogo","year":"2018","journal-title":"Case Rep Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib45","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/j.ajkd.2004.12.017","article-title":"Thrombotic thrombocytopenic purpura in a patient treated with imatinib mesylate: true association or mere coincidence?","volume":"45","author":"Al Aly","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1078155214568580","article-title":"Secondary thrombotic microangiopathy in two patients with Philadelphia-positive hematological malignancies treated with imatinib mesylate","volume":"22","author":"Ojeda-Uribe","year":"2016","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib47","first-page":"29","article-title":"A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib","volume":"2","author":"Martino","year":"2013","journal-title":"Leuk Res Rep"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.transci.2018.02.003","article-title":"Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura","volume":"57","author":"Demirsoy","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"20","key":"10.1053\/j.ackd.2022.02.003_bib49","first-page":"30118-7","article-title":"Carfilzomib-induced thrombotic microangiopathy: a case based review","volume":"S1658-3876","author":"Jindal","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib50","doi-asserted-by":"crossref","first-page":"e5.1","DOI":"10.1053\/ajkd.2000.8304","article-title":"Renal thrombotic microangiopathy associated with interferon-\u03b1 treatment of chronic myeloid leukemia","volume":"36","author":"Magee","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib51","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/ijn.IJN_54_17","article-title":"Renal vein thrombosis as presentation of non-M3 acute myeloid leukemia in an adult patient","volume":"28","author":"Sureka","year":"2018","journal-title":"Indian J Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib52","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.7326\/0003-4819-12-10-1690","article-title":"Hypertension and constriction of the renal arteries in man: report of a case","volume":"12","author":"Blatt","year":"1939","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00432526","article-title":"Pathoanatomical features of the kidney in myelomonocytic and chronic lymphocytic leukemia","volume":"368","author":"Schwarze","year":"1975","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib54","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/1097-0142(19870815)60:4<827::AID-CNCR2820600419>3.0.CO;2-A","article-title":"An autopsy study of 1206 acute and chronic leukemias (1958 to 1982)","volume":"60","author":"Barcos","year":"1987","journal-title":"Cancer"},{"issue":"3-4","key":"10.1053\/j.ackd.2022.02.003_bib55","first-page":"147","article-title":"Renal involvement in myeloproliferative and lymphoproliferative disorders. A study of autopsy cases","volume":"142","author":"Xiao","year":"1997","journal-title":"Gen Diagn Pathol"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5301\/jo-n.5000022","article-title":"Chronic lymphocytic leukemia and the kidney","volume":"1","author":"Sethi","year":"2017","journal-title":"J Onco-Nephrology"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib57","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-5347(17)52099-6","article-title":"Early renal involvement in acute lymphoblastic leukemia and Nonhodgkin\u2019s lymphoma in children","volume":"129","author":"Gilboa","year":"1983","journal-title":"J Urol"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0272-6386(87)80077-X","article-title":"Primary renal lymphoma presenting as acute renal failure","volume":"9","author":"Truong","year":"1987","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib59","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ajkd.2003.08.004","article-title":"Lymphomas diagnosed by percutaneous kidney biopsy","volume":"42","author":"T\u00f6rnroth","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1272\/jnms.JNMS.2020_87-108","article-title":"Primary tumor infiltration and severe acute kidney injury in patients with acute Myeloblastic leukemia","volume":"87","author":"Aratani","year":"2020","journal-title":"J Nippon Med Sch"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib61","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.kint.2019.01.027","article-title":"Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders","volume":"96","author":"Javaugue","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib62","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1634\/theoncologist.2017-0147","article-title":"In-hospital outcomes of tumor lysis syndrome: a population-based study using the National Inpatient sample","volume":"22","author":"Durani","year":"2017","journal-title":"Oncologist"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo","year":"2004","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib64","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/1078-0432.CCR-12-1092","article-title":"A Pharmacokinetic\/Pharmacodynamic Model of tumor lysis syndrome in chronic lymphocytic leukemia patients treated with flavopiridol","volume":"19","author":"Ji","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1053\/j.ackd.2022.02.003_bib65","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/leu.2015.31","article-title":"Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia","volume":"29","author":"Flynn","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib66","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-015-2585-7","article-title":"Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review","volume":"95","author":"Howard","year":"2016","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib67","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MAJ.0b013e318244db6f","article-title":"Diagnosis and treatment of rituximab-induced acute tumor lysis syndrome in patients with diffuse large B-cell lymphoma","volume":"343","author":"Yang","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ackd.2022.02.003_bib68","doi-asserted-by":"crossref","first-page":"610969","DOI":"10.1155\/2010\/610969","article-title":"Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma","volume":"2010","author":"Opyrchal","year":"2010","journal-title":"Case Rep Med"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib69","article-title":"Spontaneous tumor lysis syndrome: a case report and Critical evaluation of Current diagnostic criteria and optimal treatment Regimens","volume":"3","author":"Weeks","year":"2015","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib70","doi-asserted-by":"crossref","first-page":"e234122","DOI":"10.1136\/bcr-2019-234122","article-title":"Spontaneous tumour lysis syndrome in multiple myeloma with loss of 17p13.1, t(4;14) and monosomy 13","volume":"14","author":"Tbakhi","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14740\/jh620","article-title":"Spontaneous tumor lysis syndrome: a rare presentation in Plasmablastic lymphoma","volume":"10","author":"Infante","year":"2021","journal-title":"J Hematol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ccr3.495","article-title":"Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm","volume":"4","author":"Sherwood","year":"2016","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib73","first-page":"307","article-title":"Massive uric acid nephrolithiasis with progressive renal failure due to spontaneous tumour lysis syndrome","volume":"1","author":"Trachsler","year":"2008","journal-title":"NDT Plus"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib74","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.03150312","article-title":"Onco-nephrology: tumor lysis syndrome","volume":"7","author":"Wilson","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5492\/wjccm.v4.i2.130","article-title":"Tumor lysis syndrome: a clinical review","volume":"4","author":"Mirrakhimov","year":"2015","journal-title":"World J Crit Care Med"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ekir.2020.12.005","article-title":"Kidney involvement in patients with chronic myelomonocytic leukemia or BCR-ABL\u2013negative myeloproliferative neoplasms","volume":"6","author":"Belliere","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib77","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41581-021-00405-7","article-title":"Kidney injury and disease in patients with haematological malignancies","volume":"17","author":"Bridoux","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1053\/j.ackd.2022.02.003_bib78","first-page":"70","article-title":"Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era","volume":"5","author":"Del Sordo","year":"2017","journal-title":"Clin Nephrol Case Stud"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib79","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2015.117","article-title":"Renal extramedullary hematopoiesis: interstitial and glomerular pathology","volume":"28","author":"Alexander","year":"2015","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1053\/j.ackd.2022.02.003_bib80","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.2011.147","article-title":"Myeloproliferative neoplasms cause glomerulopathy","volume":"80","author":"Said","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ackd.2022.02.003_bib81","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2215\/CJN.13041117","article-title":"Kidney involvement of patients with Waldenstrom macroglobulinemia and other IgM-Producing B cell lymphoproliferative disorders","volume":"13","author":"Higgins","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1-2","key":"10.1053\/j.ackd.2022.02.003_bib82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/2399369319899098","article-title":"Acute kidney injury in a patient with lymphoma","volume":"4","author":"Perazella","year":"2020","journal-title":"J Onco-Nephrology"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib83","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anndiagpath.2015.03.003","article-title":"Granulomatous interstitial nephritis secondary to chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"19","author":"Nasr","year":"2015","journal-title":"Ann Diagn Pathol"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib84","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1093\/ndt\/gfq489","article-title":"Granulomatous interstitial nephritis in chronic lymphocytic leukaemia","volume":"25","author":"Inoue","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib85","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12882-017-0775-3","article-title":"Granulomatous interstitial nephritis due to chronic lymphocytic leukemia: a case report","volume":"18","author":"Suzuki","year":"2017","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib86","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ekir.2016.09.002","article-title":"Lysozyme-induced nephropathy","volume":"2","author":"Santoriello","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000045738","article-title":"Proteinuria caused by lysozymuria mimics nephrotic syndrome","volume":"86","author":"Aguado","year":"2000","journal-title":"Nephron"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib88","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0272-6386(12)70154-3","article-title":"Renal failure and severe Hypokalemia associated with acute myelomonocytic leukemia","volume":"22","author":"Perazella","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/0003-4819-121-10-199411150-00020","article-title":"Pseudonephrotic syndrome caused by lysozymuria","volume":"121","author":"Mok","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.annpat.2020.04.001","article-title":"[Lysozyme-induced nephropathy: a rare cause of renal failure in chronic myelomonocytic leukemia]","volume":"40","author":"Robinet-Zimmermann","year":"2020","journal-title":"Ann Pathol"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib91","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s13730-020-00567-6","article-title":"A rare cause of acute kidney injury with chronic myelomonocytic leukemia","volume":"10","author":"Asano","year":"2021","journal-title":"CEN Case Rep"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib92","first-page":"34","article-title":"Clinical management of ureteral obstruction secondary to malignant lymphoma","volume":"134","author":"Abeloff","year":"1974","journal-title":"Johns Hopkins Med J"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib93","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0002-9343(62)90289-9","article-title":"Renal lesions associated with malignant lymphomas","volume":"32","author":"Richmond","year":"1962","journal-title":"Am J Med"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib94","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1445-5994.1981.tb04628.x","article-title":"Anuric renal failure due to encasement of the ureters by lymphoma--ureteric obstruction without dilatation","volume":"11","author":"Chong","year":"1981","journal-title":"Aust N Z J Med"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)56223-0","article-title":"Idiopathic retroperitoneal fibrosis","volume":"122","author":"Lepor","year":"1979","journal-title":"J Urol"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib96","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bjc.1973.171","article-title":"Retroperitoneal fibrosis associated with malignant disease","volume":"28","author":"Thomas","year":"1973","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib97","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1078155214543279","article-title":"Retroperitoneal fibrosis due to B-cell non-Hodgkin lymphoma: Responding to rituximab","volume":"22","author":"Alvarez Argote","year":"2014","journal-title":"J Oncol Pharm Pract"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib98","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1080\/10428194.2018.1427857","article-title":"Retroperitoneal fibrosis as extramedullary hematopoiesis of a chronic myelomonocytic leukemia","volume":"59","author":"Ricard","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib99","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","article-title":"Treatment approaches to IgG4-related systemic disease","volume":"23","author":"Khosroshahi","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/14397595.2018.1554321","article-title":"IgG4-related kidney disease and retroperitoneal fibrosis: an update","volume":"29","author":"Kawano","year":"2019","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib102","doi-asserted-by":"crossref","first-page":"721","DOI":"10.5694\/j.1326-5377.1992.tb121515.x","article-title":"Non-dilated urinary tract obstruction","volume":"156","author":"Somerville","year":"1992","journal-title":"Med J Aust"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib103","first-page":"439","article-title":"Idiopathic fibrosis as the cause of obstructive uropathy","volume":"33","author":"Santos","year":"2013","journal-title":"Nefrologia"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib104","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archinte.1983.00350040086011","article-title":"Nondilated obstructive nephropathy","volume":"143","author":"Rascoff","year":"1983","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0090-4295(88)90211-7","article-title":"Nondilated obstructive uropathy","volume":"31","author":"Spital","year":"1988","journal-title":"Urology"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejim.2015.03.004","article-title":"Erdheim-Chester disease","volume":"26","author":"Campochiaro","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1053\/j.ackd.2022.02.003_bib107","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.lpm.2016.07.010","article-title":"Erdheim Chester disease: a rare obstructive case of acute renal failure","volume":"45","author":"Jean-Michel","year":"2016","journal-title":"La Presse M\u00e9dicale"},{"key":"10.1053\/j.ackd.2022.02.003_bib108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.urology.2020.06.013","article-title":"A rare case of T-cell lymphoma presenting with bilateral nephrolithiasis and acute renal failure","volume":"146","author":"Cochran","year":"2020","journal-title":"Urology"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib109","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1590\/S1677-5538.IBJU.2014.06.08","article-title":"What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?","volume":"40","author":"Mirheydar","year":"2014","journal-title":"Int Braz J Urol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib111","doi-asserted-by":"crossref","first-page":"e2011059","DOI":"10.4084\/mjhid.2011.059","article-title":"The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature","volume":"3","author":"Montesinos","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib112","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/j.ajkd.2019.10.011","article-title":"Acute kidney injury and electrolyte abnormalities after chimeric antigen receptor T-cell (CAR-T) therapy for diffuse large B-cell lymphoma","volume":"76","author":"Gupta","year":"2020","journal-title":"Am J kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib113","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2014.10.012","article-title":"Acute kidney injury in adults with hemophagocytic lymphohistiocytosis","volume":"65","author":"Aulagnon","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib114","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005792-198811000-00002","article-title":"Hematophagic histiocytosis: a report of 23 new patients and a review of the literature.","volume":"67","author":"Reiner","year":"1988","journal-title":"Medicine"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MD.0000000000000022","article-title":"Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients","volume":"93","author":"Li","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26642","article-title":"Severe cytokine release syndrome in a patient receiving PD-1-directed therapy","volume":"64","author":"Rotz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib117","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbmt.2020.02.012","article-title":"Acute kidney injury after CAR-T cell therapy: low incidence and rapid Recovery","volume":"26","author":"Gutgarts","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib118","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.ajkd.2020.08.017","article-title":"Acute kidney injury after the CAR-T therapy Tisagenlecleucel","volume":"77","author":"Lee","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib119","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.bbmt.2018.12.756","article-title":"Cytokine release syndrome with chimeric antigen receptor T cell therapy","volume":"25","author":"Frey","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/bjh.16455","article-title":"Lysozyme-induced nephropathy: a rare manifestation of chronic myelomonocytic leukaemia","volume":"189","author":"Maraj","year":"2020","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib121","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/10428190290021443","article-title":"Acute myeloid leukemia associated with nephrotic syndrome: case report and literature review","volume":"43","author":"Levi","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib122","first-page":"59","article-title":"Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia","volume":"48","author":"Budak-Alpdo\u011fan","year":"1997","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2022.02.003_bib123","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000068492","article-title":"A case of chronic myeloid leukemia complicated with minimal change nephrotic syndrome","volume":"109","author":"Talwar","year":"2003","journal-title":"Acta Haematol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib124","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archinte.1983.00350010180036","article-title":"Chronic myelogenous leukemia with nephrotic syndrome","volume":"143","author":"Sudholt","year":"1983","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0002-9343(86)90433-X","article-title":"Chronic myelogenous leukemia and glomerulonephritis: report of a new case","volume":"81","author":"Gago","year":"1986","journal-title":"Am J Med"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib126","first-page":"799","article-title":"Nephrotic syndrome in the possible terminal blast-cell crisis in myeloid leukaemia (a case report)","volume":"20","author":"Agarwal","year":"1972","journal-title":"J Assoc Physicians India"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib127","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/ndt\/9.5.562","article-title":"Chronic myelogenous leukaemia associated with rapidly progressive glomerulonephritis","volume":"9","author":"Majdan","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<200::AID-AJH6>3.0.CO;2-0","article-title":"Myelodysplastic syndromes with nephrotic syndrome","volume":"60","author":"Saitoh","year":"1999","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib129","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s004670100025","article-title":"Glomerular involvement in myelodysplastic syndromes","volume":"16","author":"Bogdanovi\u0107","year":"2001","journal-title":"Pediatr Nephrology"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib130","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/his.14282","article-title":"Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome\/myeloproliferative neoplasms","volume":"78","author":"B\u00fcttner-Herold","year":"2021","journal-title":"Histopathology"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib131","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(99)70047-8","article-title":"Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders","volume":"34","author":"Au","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ackd.2022.02.003_bib132","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1681\/ASN.V881266","article-title":"Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-\u03b2","volume":"8","author":"Ruiz-Ortega","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib133","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Floege","year":"2008","journal-title":"J Am Soc Nephrol: JASN"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib134","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ekir.2020.12.030","article-title":"Spectrum of kidney involvement in patients with myelodysplastic syndromes","volume":"6","author":"Schwotzer","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib135","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1016\/S0272-6386(99)70032-6","article-title":"Amyloidosis complicating idiopathic myelofibrosis","volume":"34","author":"Chan","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib136","first-page":"525","article-title":"Amyloidosis complicating idiopathic myelofibrosis","volume":"111","author":"Akikusa","year":"1987","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib137","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10157-006-0437-4","article-title":"Concurrent FSGS and Hodgkin\u2019s lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies","volume":"10","author":"Mallouk","year":"2006","journal-title":"Clin Exp Nephrology"},{"issue":"11","key":"10.1053\/j.ackd.2022.02.003_bib138","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1007\/s00467-004-1591-0","article-title":"Acute lymphoblastic leukemia in a child with nephrotic syndrome.","volume":"19","author":"Bhatia","year":"2004","journal-title":"Pediatr Nephrology"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib139","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00043426-199809000-00015","article-title":"Focal segmental glomerulosclerosis in children with acute lymphocytic leukemia: case reports and review of literature","volume":"20","author":"Sathiapalan","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2022.02.003_bib140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2015-02-585059","article-title":"Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification","volume":"126","author":"Strati","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib141","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney involvement and renal manifestations in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients","volume":"67","author":"Da\u2019As","year":"2001","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib142","doi-asserted-by":"crossref","first-page":"e0119156","DOI":"10.1371\/journal.pone.0119156","article-title":"The spectrum of kidney pathology in B-cell chronic lymphocytic leukemia\/small lymphocytic lymphoma: a 25-year multicenter experience","volume":"10","author":"Poitou-Verkinder","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.ackd.2022.02.003_bib143","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bcmd.2016.05.009","article-title":"Cryoglobulinemia in a patient with chronic lymphocytic leukemia - a case report and review of literature of renal involvement in CLL","volume":"60","author":"Arora","year":"2016","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib144","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ki.1992.270","article-title":"Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas","volume":"42","author":"Moulin","year":"1992","journal-title":"Kidney Int"},{"key":"10.1053\/j.ackd.2022.02.003_bib145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1746-1596-6-99","article-title":"Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review","volume":"6","author":"Dou","year":"2011","journal-title":"Diagn Pathol"},{"issue":"11","key":"10.1053\/j.ackd.2022.02.003_bib146","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.mayocp.2013.08.002","article-title":"Monoclonal gammopathy-associated proliferative glomerulonephritis","volume":"88","author":"Sethi","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib147","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nefro.2020.08.010","article-title":"C3 glomerulopathy associated to B-cell chronic lymphocytic leukemia","volume":"42","author":"Silva","year":"2022","journal-title":"Nefrologia"},{"issue":"11","key":"10.1053\/j.ackd.2022.02.003_bib148","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2016-08-737163","article-title":"Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy\u2013associated C3 glomerulopathy","volume":"129","author":"Chauvet","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib149","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archinte.1986.00360130167023","article-title":"A review of nephrotic syndrome associated with chronic lymphocytic leukemia","volume":"146","author":"Seney","year":"1986","journal-title":"Arch Intern Med"},{"issue":"24","key":"10.1053\/j.ackd.2022.02.003_bib150","first-page":"350","article-title":"Minimal change nephrotic syndrome associated with non-hodgkin lymphoid disorders: a retrospective study of 18 cases","volume":"93","author":"Kofman","year":"2014","journal-title":"Medicine (United States)"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib151","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ackd.2013.08.003","article-title":"Glomerular diseases associated with cancer, chemotherapy, and hematopoietic stem cell transplantation","volume":"21","author":"Jhaveri","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1053\/j.ackd.2022.02.003_bib152","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/sj.ki.5000341","article-title":"Minimal change nephrotic syndrome and classical Hodgkin\u2019s lymphoma: report of 21 cases and review of the literature","volume":"69","author":"Audard","year":"2006","journal-title":"Kidney International"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib153","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0272-6386(98)70134-9","article-title":"Epstein-Barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury","volume":"32","author":"Iwama","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib154","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0145-2126(02)00277-1","article-title":"Monoclonal gammopathies in B-cell non-Hodgkin\u2019s lymphomas","volume":"27","author":"Economopoulos","year":"2003","journal-title":"Leuk Res"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","article-title":"Glomerular diseases seen with cancer and chemotherapy: a narrative review","volume":"84","author":"Jhaveri","year":"2013","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib156","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.ki.5000352","article-title":"Nephrotic syndrome associated with hemophagocytic syndrome","volume":"69","author":"Thaunat","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2022.02.003_bib157","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12882-015-0217-z","article-title":"Acute kidney injury induced by thrombotic microangiopathy in a patient with hemophagocytic lymphohistiocytosis","volume":"17","author":"Bae","year":"2016","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2022.02.003_bib158","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2009.73","article-title":"What nephrologists need to know about hemophagocytic syndrome","volume":"5","author":"Karras","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2022.02.003_bib159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJM197007162830304","article-title":"Pathology of the kidney in Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"283","author":"Morel-Maroger","year":"1970","journal-title":"New Engl J Med Mass Med Soc"},{"issue":"5","key":"10.1053\/j.ackd.2022.02.003_bib160","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1053\/j.ajkd.2015.03.035","article-title":"Kidney diseases associated with monoclonal immunoglobulin M-Secreting B-cell lymphoproliferative disorders: a case series of 35 patients","volume":"66","author":"Chauvet","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ackd.2022.02.003_bib161","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood-2016-04-711234","article-title":"Treatment recommendations from the Eighth International Workshop on Waldenstr\u00f6m\u2019s macroglobulinemia","volume":"128","author":"Leblond","year":"2016","journal-title":"Blood"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559522000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559522000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:04:43Z","timestamp":1761548683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559522000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":161,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1548559522000313"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2022.02.003","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematological Malignancies and the Kidney","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}